162 related articles for article (PubMed ID: 10924965)
1. Confirmation of improved local-regional control with altered fractionation in head and neck cancer.
Fowler JF; Harari PM
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):3-6. PubMed ID: 10924965
[No Abstract] [Full Text] [Related]
2. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard-fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to Fu et al. IJROBP 2000;48:7-16. Actuarial estimates of late normal-tissue effects...now!
Dubben HH; Beck-Bornholdt HP
Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):563. PubMed ID: 11579925
[No Abstract] [Full Text] [Related]
3. Altered fractionation in radiotherapy for head and neck cancer: too early to close the race and announce the winner?
Bentzen SM; Dische S
Radiother Oncol; 1999 May; 51(2):105-7. PubMed ID: 10435799
[No Abstract] [Full Text] [Related]
4. Altered fractionation in radiation therapy for squamous-cell carcinoma of the head and neck.
Mendenhall WM; Parsons JT
Cancer Invest; 1998; 16(8):594-603. PubMed ID: 9844620
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy and altered fractionation in head-and-neck cancer: in regard to Staar et al., IJROBP 2001;50:1161-1171.
Bentzen SM; Bernier J
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1423; author reply 1423-4. PubMed ID: 11955758
[No Abstract] [Full Text] [Related]
6. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.
Fu KK; Pajak TF; Trotti A; Jones CU; Spencer SA; Phillips TL; Garden AS; Ridge JA; Cooper JS; Ang KK
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):7-16. PubMed ID: 10924966
[TBL] [Abstract][Full Text] [Related]
7. Status of accelerated fractionation radiotherapy in head and neck squamous cell carcinomas.
Bourhis J; Wibault P; Lusinchi A; Bobin S; Luboinski B; Eschwege F
Curr Opin Oncol; 1997 May; 9(3):262-6. PubMed ID: 9229149
[TBL] [Abstract][Full Text] [Related]
8. Altered fractionation in definitive irradiation of squamous cell carcinoma of the head and neck.
Mendenhall WM; Amdur RJ; Siemann DW; Parsons JT
Curr Opin Oncol; 2000 May; 12(3):207-14. PubMed ID: 10841192
[TBL] [Abstract][Full Text] [Related]
9. Altered fractionation radiotherapy in head and neck squamous cell carcinoma.
Mallick S; Benson R; Julka PK; Rath GK
J Egypt Natl Canc Inst; 2016 Jun; 28(2):73-80. PubMed ID: 26994645
[TBL] [Abstract][Full Text] [Related]
10. Altered fractionation radiotherapy in head and neck cancer: clinical issues and pitfalls of "evidence-based medicine".
Antognoni P; Corvò R; Zerini D; Orecchia R
Tumori; 2005; 91(1):30-9. PubMed ID: 15850002
[TBL] [Abstract][Full Text] [Related]
11. Altered fractionation in the treatment of head and neck cancer.
Hu KS; Harrison LB
Curr Oncol Rep; 1999; 1(2):110-23. PubMed ID: 11122807
[TBL] [Abstract][Full Text] [Related]
12. Fractionation sensitivities and dose-control relations of head and neck carcinomas: analysis of the randomized hyperfractionation trials.
Stuschke M; Thames HD
Radiother Oncol; 1999 May; 51(2):113-21. PubMed ID: 10435801
[TBL] [Abstract][Full Text] [Related]
13. In response to Drs. Dubben, Beck-Bornholdt, and Llogie.
Ang KK; Berkey BA; Pajak TF; Fu KK
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1148-50. PubMed ID: 11958923
[No Abstract] [Full Text] [Related]
14. Radiation therapy in the management of early-stage head and neck cancer.
Hinerman RW; Mendenhall WM; Amdur RJ
Cancer Treat Res; 2003; 114():115-44. PubMed ID: 12619540
[No Abstract] [Full Text] [Related]
15. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.
Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002
[TBL] [Abstract][Full Text] [Related]
16. Unexpected radiation laryngeal necrosis after carbon ion therapy using conventional dose fractionation for laryngeal cancer.
Demizu Y; Fujii O; Nagano F; Terashima K; Jin D; Mima M; Oda N; Takeuchi K; Takeda M; Ito K; Fuwa N; Okimoto T
Jpn J Clin Oncol; 2015 Nov; 45(11):1076-81. PubMed ID: 26355161
[TBL] [Abstract][Full Text] [Related]
17. Altered radiation therapy fractionation, chemoradiation, and patient selection for the treatment of head and neck squamous carcinoma.
Rosenthal DI; Ang KK
Semin Radiat Oncol; 2004 Apr; 14(2):153-66. PubMed ID: 15095261
[TBL] [Abstract][Full Text] [Related]
18. The DAHANCA 6 randomized trial: Effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma.
Lyhne NM; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Evensen J; Mortensen HR; Overgaard J
Radiother Oncol; 2015 Oct; 117(1):91-8. PubMed ID: 26255764
[TBL] [Abstract][Full Text] [Related]
19. [Not Available].
Klages HT
Strahlenther Onkol; 2014 Oct; 190(10):970-2. PubMed ID: 25392873
[No Abstract] [Full Text] [Related]
20. Systematic Review and Meta-analysis of Conventionally Fractionated Concurrent Chemoradiotherapy versus Altered Fractionation Radiotherapy Alone in the Definitive Management of Locoregionally Advanced Head and Neck Squamous Cell Carcinoma.
Gupta T; Kannan S; Ghosh-Laskar S; Agarwal JP
Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):50-61. PubMed ID: 26454839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
